Article published Aug 14, 2026. Prices below use latest available snapshots.
Editorial Note: NVDA at $192.53 RSI 37.9 is the cleanest AI-infra entry setup in the cohort this week. The stock has pulled back -7.28% in 7D and -9.33% in 30D, but the golden cross remains firmly intact and the 3M return of +15.07% confirms the Blackwell ramp thesis is still running. RSI 37.9 is the deepest oversold-adjacent read in this series so far — and it has arrived at a structurally significant level: the SMA200 at $190.43 is only 1.1% below current price. Price at $192.53 is just 3.27% above VWAP ($186.44), meaning the stock is now trading near the average cost of all market participants over the past period — not extended, not dislocated to the downside, just sitting at equilibrium. The -7.3% below SMA20 ($207.71) shows the near-term trend is weak but the golden cross (SMA50 $209.92 > SMA200 $190.43) remains intact — the structural signal that brought NVDA out of the April hole has not reversed. Regime "pullback" confirms this reads as healthy digestion of the Blackwell ramp, not a Blackwell thesis break. The prior base target of $212 (reached in May) has pulled back to $207 SMA20 — now the first reclaim target. The EOW direction: NVDA is the member of the AI-infra cohort that held structural integrity (golden cross, pullback regime, SMA200 support within reach) while MSFT/ORCL/PLTR broke structure entirely. At RSI 37.9 with SMA200 only 1% below, this is the re-entry zone the Blackwell thesis warrants.
2026-07-11 tape check: The entry-zone call played out. NVDA bounced from $192.53 to $210.96 (+9.6%), RSI recovered from 37.9 to 57.2, and price has reclaimed SMA20 ($201.95, +4.5% above) — exceeding the prior $207 base target. It's now only +0.9% above SMA50 ($209.07) and +10.2% above SMA200 ($191.47); golden cross remains intact throughout. 7D +7.32%, 30D +2.97% (flipped positive from -9.33%), and drawdown from the 52-week high improved to -10.81% (from -18.61%). 3M ticked down to +11.57% from +15.07% — a rolling-window base effect, not a reversal, given the outright price gain and every other indicator improving. No divergence: this is the thesis confirming cleanly. Next reference point is the $250+ bull target.
2026-07-17 tape check: A pullback has erased the 07/11 bounce. NVDA $202.81, RSI 48.1 (down from 57.2), now essentially flat vs SMA20 (+0.3%, down from +4.5%) and -3.3% below SMA50 (was +0.9% above). 7D -2.21%, 30D -3.74% (flipped negative), 3M +0.49% (flat). -14.26% from 52wk high (widened from -10.81%). Golden cross still intact (+5.5% above SMA200), regime "pullback," thesis flag "intact." No new fundamentals re-researched — this reads as digesting the 07/11 bounce rather than a fresh breakdown.
2026-07-25 tape check (Friday 2026-07-24 close): The digestion has resolved back upward. NVDA $206.84 (+2.0% vs $202.81), RSI 51 (up from 48.1) — +1.7% above SMA20 (up from +0.3%) and -1.1% below SMA50 (narrowed from -3.3%). 7D has flipped positive to +1.99% (from -2.21%), 30D has flipped positive to +3.94% (from -3.74%), and 3M is roughly flat at -0.57% (from +0.49%). -11.74% from 52wk high — narrowed from -14.26%. Golden cross still intact (+7.3% above SMA200), regime "pullback," thesis flag "intact." No new fundamentals re-researched.
2026-07-28 tape check: The upward resolution has reversed. NVDA $197.01 (-4.75% vs $206.84), RSI 43 (down from 51) — back to -3.3% below SMA20 (from +1.7% above) and -5.2% below SMA50 (widened from -1.1%). 7D has flipped negative to -4.96% (from +1.99%), 30D has moderated to +1.05% (from +3.94%), and 3M has deepened to -5.74% (from -0.57%). -16.71% from 52wk high — widened from -11.74%. Golden cross still intact (+2.2% above SMA200, a narrower cushion than +7.3%), regime "pullback," thesis flag "intact." No new fundamentals re-researched; this reads as a fresh leg of digestion within the pullback, not a break of the Blackwell ramp thesis.
2026-07-31 tape note: NVDA $200.75 (+1.90% vs $197.01), RSI 48.6 (warmed from 43). 7D -2.94% (moderated from -4.96%), 30D +1.60% (accelerated from +1.05%), 3M +1.28% (turned positive from -5.74%). From the 52-week high, the gap is -15.13% (narrowed from -16.71%). Per the tape: trend "weak-down", regime "pullback", golden cross intact. No new fundamentals re-researched. Per the full-scan summaries (2026-07-31 close). 2026-08-08 tape note: NVDA $223.96 (+11.56% vs $200.75), RSI 64.5 (warmed from 48.6). 7D +11.56% (turned positive from -2.94%), 30D +9.72% (accelerated from +1.60%), 3M +4.19% (accelerated from +1.28%). From the 52-week high, the gap is -7.32% (narrowed from -15.13%). Per the tape: trend "strong-up", regime "uptrend", golden cross intact. No new fundamentals re-researched. Per the full-scan summaries (2026-08-07 close). 2026-08-14 tape note: NVDA $225.16 (+0.54% vs $223.96), RSI 62.8 (cooled from 64.5). 7D +0.54% (moderated from +11.56%), 30D +5.96% (moderated from +9.72%), 3M +0.04% (moderated from +4.19%). From the 52-week high, the gap is -4.75% (narrowed from -7.32%). Per the tape: trend "strong-up", regime "basing", golden cross intact. No new fundamentals re-researched. Per the full-scan summaries (2026-08-14 close).
Quick Snapshot
| Indicator | Value | Signal |
|---|---|---|
| RSI (14) | 48.6 | neutral, warmed from 43 |
| Trend | Weak-down | Unchanged |
| Golden cross | Yes | Intact, narrower cushion |
| SMA20 vs Price | -1.3% below | narrowed |
| SMA50 vs Price | -2.6% below | narrowed |
| SMA200 vs Price | +4.1% above | widened |
| 7D return | -2.94% | moderated from -4.96% |
| 30D return | +1.60% | accelerated from +1.05% |
| 3M return | +1.28% | turned positive from -5.74% |
| From 52wk High | -15.13% | Gap narrowed from -16.71% |
| Regime | Pullback | Unchanged |
Action Matrix
| Scenario | Level | Notes |
|---|---|---|
| Entry zone | $185–$195 | Price has drifted back toward this zone |
| Stop-loss | $165 | Below SMA200 + structure — unchanged |
| Target (base) | $207 | SMA20 reclaim — price just below it now |
| Target (bull) | $250+ | Blackwell super-cycle — next reference point |
| Current | RSI 48.6, weak-down | pullback, -15.1% from 52wk high |
Price Data
| Metric | Value |
|---|---|
| Price | $225.16 |
| RSI (14) | 62.8 |
| SMA20 | $210.40 (+7.0%) |
| SMA50 | $206.52 (+9.0%) |
| SMA200 | $194.75 (+15.6%) |
| Trend | strong-up |
| Golden cross | Yes |
| Regime | basing |
| 7D | +0.54% |
| 30D | +5.96% |
| 3M | +0.04% |
| From 52wk High | -4.75% |
Key Changes vs 07/28
| Metric | 07/28 | 07/31 | Change |
|---|---|---|---|
| Price | $197.01 | $200.75 | up |
| RSI | 43 | 48.6 | warmed |
| SMA20 vs Price | -3.3% | -1.3% | narrowed |
| SMA50 vs Price | -5.2% | -2.6% | narrowed |
| 30D | +1.05% | +1.60% | accelerated |
| 3M | -5.74% | +1.28% | turned positive |
| From 52wkHi | -16.71% | -15.13% | narrowed |
| Golden cross | Yes | Yes | Unchanged |
| Verdict | Tape update: price now $200.75 (+1.9% vs prior refresh), RSI 48.6, trend "weak-down", -15.1% from 52wk high. No new fundamentals re-researched this cycle. |
Research Log
| Date | Note |
|---|---|
| 2026-05-29 | NVDA $211.14, RSI 49.4, strong-up; +5.8% 30D, +15.71% 3M. Base target $212 effectively reached. |
| 2026-06-16 | NVDA $207.41, RSI 47.4, neutral; -6.6% 30D, +14.14% 3M. Continued mild consolidation. Golden cross intact. |
| 2026-06-26 | NVDA $192.53, RSI 37.9, weak-down; -7.28% 7D, -9.33% 30D, +15.07% 3M. Flushed to SMA200 ($190.43) zone — structural support. Golden cross intact, regime "pullback," VWAP $186.44 (price +3.27% above). RSI 37.9 is the deepest near-oversold read in this series. This is the entry zone the Blackwell thesis warrants: golden cross + pullback regime + at SMA200 + near-VWAP + RSI near oversold. Cleanest AI-infra entry of the EOW cohort. No new fundamentals re-researched. |
| 2026-07-11 | NVDA $210.96, RSI 57.2, strong-up; 7D +7.32%, 30D +2.97%, 3M +11.57%; -10.81% from 52wkHi; +4.5% above SMA20 ($201.95), golden cross intact. Prior base target ($207 SMA20 reclaim) exceeded — the 06-26 entry-zone call played out cleanly. No divergence. No new fundamentals re-researched. |
| 2026-07-17 | NVDA $202.81, RSI 48.1, weak-down/pullback; 7D -2.21%, 30D -3.74%, 3M +0.49%; -14.26% from 52wkHi; +0.3% above SMA20, -3.3% below SMA50, golden cross intact. Gave back the 07/11 bounce — reads as digestion, not a breakdown. No new fundamentals re-researched. |
| 2026-07-25 | NVDA $206.84, RSI 51, weak-down/pullback; 7D +1.99%, 30D +3.94%, 3M -0.57%; -11.74% from 52wkHi; +1.7% above SMA20, -1.1% below SMA50, golden cross intact. Digestion resolved back upward. No new fundamentals re-researched. |
| 2026-07-28 | NVDA $197.01, RSI 43, weak-down/pullback; 7D -4.96%, 30D +1.05%, 3M -5.74%; -16.71% from 52wkHi; -3.3% below SMA20, -5.2% below SMA50, golden cross intact (narrower cushion, +2.2% above SMA200). Upward resolution reversed. No new fundamentals re-researched. |
| 2026-07-31 | NVDA $200.75, RSI 48.6, weak-down; 7D -2.94%; 30D +1.60%; 3M +1.28%; -15.13% from 52wk high. No new fundamentals re-researched. |
| 2026-08-08 | NVDA $223.96, RSI 64.5, strong-up; 7D +11.56%; 30D +9.72%; 3M +4.19%; -7.32% from 52wk high. No new fundamentals re-researched. |
| 2026-08-14 | NVDA $225.16, RSI 62.8, strong-up; 7D +0.54%; 30D +5.96%; 3M +0.04%; -4.75% from 52wk high. No new fundamentals re-researched. |
Sources
- Tape data (price/RSI/SMA/returns): full-scan pre-computed summaries as of the 2026-07-31 close — *.
- Prior-cycle history: this file's dated update log (refreshed each full scan).